Helps maintain a healthy weight
Eli Lilly used its voucher for orforglipron, approved on April 1, 2026, under the brand name Foundayo, and described by the agency as the fastest approval of a new molecular entity since 2002
Interestingly, albuminuria reductions in EMPA-REG OUTCOME persisted in participants with baseline albuminuria even after drug washout, suggesting renal structural changes beyond simple hemodynamic effects 28
The Centers for Medicare & Medicaid Innovation Center is working with drug makers like Eli Lilly and Novo Nordisk to make GLP-1 medications more affordable for state Medicaid programs and beneficiaries alike
Weight-based dosing reference: 15 to 30 mcg/kg body weight
Wang L, Chen T, Wang H, Wu X, Cao Q, Wen K, et al